XML 24 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Reserve For Losses, LAE And Future Policy Benefit Reserve
9 Months Ended
Sep. 30, 2021
Reserve For Losses, LAE And Future Policy Benefit Reserve [Abstract]  
Reserve For Losses, LAE And Future Policy Benefit Reserve

4. RESERVE FOR LOSSES, LAE AND FUTURE POLICY BENEFIT RESERVE

 

Activity in the reserve for losses and LAE is summarized for the periods indicated:

 

Nine Months Ended

 

September 30,

(Dollars in thousands)

2021

 

2020

Gross reserves beginning of period

$

16,398,997

 

$

13,611,313

Less reinsurance recoverables on unpaid losses

 

(1,843,691)

 

 

(1,640,712)

Net reserves beginning of period

 

14,555,306

 

 

11,970,601

 

 

 

 

 

 

Incurred related to:

 

 

 

 

 

Current year

 

5,577,911

 

 

4,572,640

Prior years

 

(6,050)

 

 

1,426

Total incurred losses and LAE

 

5,571,861

 

 

4,574,066

 

 

 

 

 

 

Paid related to:

 

 

 

 

 

Current year

 

1,375,665

 

 

1,015,538

Prior years

 

1,786,393

 

 

2,042,712

Total paid losses and LAE

 

3,162,058

 

 

3,058,250

 

 

 

 

 

 

Foreign exchange/translation adjustment

 

(41,000)

 

 

(28,024)

 

 

 

 

 

 

Net reserves end of period

 

16,924,109

 

 

13,458,393

Plus reinsurance recoverables on unpaid losses

 

2,032,844

 

 

1,774,732

Gross reserves end of period

$

18,956,953

 

$

15,233,125

 

 

 

 

 

 

(Some amounts may not reconcile due to rounding.)

Current year incurred losses were $5,577.9 million and $4,572.6 million for the nine months ended September 30, 2021 and 2020, respectively. Gross and net reserves increased for the nine months ended September 30, 2021, reflecting an increase in underlying exposure due to premium growth and catastrophe losses of $1,010.0 million and $355.0 million for the nine months ended September 30, 2021 and 2020, respectively. In addition, current year incurred losses for the nine months ended September 30, 2020 included $434.9 million of losses associated with the COVID-19 Pandemic which did not recur in 2021.